Search the Newsreel

3 City brokers just said it’s time to sell Legal & General shares

Legend Biotech (LEGN) Returned To Profit, Is The Stock Still Cheap?

Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Interim Chief Executive Officer - Alan BashChief Financial Officer - Carlos SantosInterim Head of R&D - Yuhong QiuDirector of Investor Relations - Caroline LeCates Paul TAKEAWAYS Worldwide Net …

Legend Biotech Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LEGN) 2026-08-11

This article first appeared on GuruFocus. Total Revenue: Increased 52% year over year, driven by continued CARVYKTI demand and commercial expansion. CARVYKTI Net Trade Sales: Approximately $657 million worldwide, representing 50% year-over-year growth and 10% sequential growth. U.S. CARVYKTI Sales: Increased 32% year over …

If You Invested $100 In ATI Stock 10 Years Ago, You Would Have This Much Today

ATI Inc. (NYSE: ATI) has significantly outperformed the market over the last decade, with an annualized return of 29.14%. An initial investment of $100 in ATI stock 10 years ago would now be worth $1,274.09, demonstrating the power of compounded returns. The article highlights …

Legend Biotech Corp (LEGN) (Q2 2026) Earnings Call Highlights: First Profitable Quarter Driven ...

This article first appeared on GuruFocus. Total Revenue: Increased 52% year over year, driven by continued CARVYKTI demand and commercial expansion. CARVYKTI Net Trade Sales: Approximately $657 million worldwide, representing 50% year-over-year growth and 10% sequential growth. U.S. CARVYKTI Sales: Increased 32% year over …

Allegheny Technologies Incorporated (ATI) extends 12-week climb to 47.7%

The specialty-materials maker’s latest weekly close came with heavier turnover, keeping attention on the durability of the move.

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Legend Biotech (NASDAQ:LEGN) surged 6% after reporting its first-ever profitable quarter in Q2 2026, with revenue of $387.5 million beating estimates and adjusted EPS of $0.16 doubling consensus. The strong performance was driven by CARVYKTI net sales reaching $657 million, up 50% year-over-year, and …

Allegion PLC stock outperforms competitors on strong trading day

Allegion PLC's stock rallied 1.76% to $168.44 on Tuesday, outperforming the broader market during a grim trading session where both the S&P 500 and Dow Jones Industrial Average declined. The company's stock closed 8.01% below its 52-week high of $183.11 reached in February.

This Budget Airline Has Officially Launched Complimentary Drinks on All Flights

Allegiant Air has launched complimentary soft drinks on all its flights, aiming to enhance customer experience. This new perk includes soda, juice, and water, with upgraded beverage options for Allegiant credit cardholders. The airline also plans to introduce a new premium seating option called …

Earnings Flash (LEGN) Legend Biotech Corporation Reports Q2 Revenue $387.5M, Vs. FactSet Est of $356.0M

Legend Biotech Corporation (LEGN) reported strong financial results for Q2, with revenues reaching $387.5 million, significantly surpassing the FactSet estimate of $356.0 million. This earnings flash highlights the company's robust revenue performance for the quarter.

Legend Biotech (NASDAQ:LEGN) Shares Gap Up After Strong Earnings

LZ SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving LegalZoom.com, Inc.

SueWallSt, powered by Levi & Korsinsky LLP, has announced an investigation into LegalZoom.com, Inc. (LZ) for potential securities law violations. This follows LegalZoom's August 5, 2026, announcement to cut its full-year revenue guidance and reduce its workforce by 13%, after previously providing higher guidance …

Legend Biotech Q2 Earnings Call Highlights

Key Points Interested in Legend Biotech Corporation Sponsored ADR? Here are five stocks we like better. CARVYKTI sales rose sharply: Worldwide net trade sales increased 50% year over year to approximately $657 million, driven by earlier-line treatment adoption in the U.S. and international expansion …

Earnings call transcript: Legend Biotech tops Q2 2026 estimates as stock rises 5%

Legend Biotech reported stronger-than-expected Q2 2026 results, achieving its first quarter of company-wide profitability with adjusted earnings of $0.16 per share and revenue of $387.5 million, significantly beating analyst estimates. The company's lead CAR-T therapy, CARVYKTI, saw worldwide net trade sales increase 50% year-over-year, …

Ex-Legend CEO takes helm at biotech startup scouring the globe for drugs

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The CEO who helped guide development of the top-selling cell therapy for multiple myeloma will take the reins of a young startup …

Legend Biotech stock rises 5% on earnings and revenue beat

Pipette dropping liquid into a test tube ©Adobe Stock Images Legend Biotech Corporation (NASDAQ:LEGN) shares gained 5.5% in pre-market trading on Tuesday after the pharmaceutical company delivered better-than-expected second-quarter earnings and revenue, supported by continued growth in CARVYKTI sales. Adjusted earnings came in at …

ATI (ATI) is a Great Momentum Stock: Should You Buy?

The article evaluates ATI Inc. (ATI) as a momentum stock, highlighting its strong Zacks Momentum Style Score of 'A' and a Zacks Rank of #2 (Buy). It points to ATI's impressive short-term price performance, outperforming both its industry and the S&P 500, along with …

Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights

Legend Biotech USA Inc. CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales increased 50% versus second quarter of 2025 to approximately $657 million Expanded CARVYKTI® availability to 348 global sites and 19 global markets with the launch of Ireland Achieved first clinical proof-of-concept for LB2501, …

Legal & General Group (LON:LGEN) Given New GBX 270 Price Target at Royal Bank Of Canada

Leggett & Platt bedding profit nearly triples to $37m as mattress market plunges 10%+

Leggett & Platt's Bedding Products business significantly increased its adjusted EBIT to $37 million in the second quarter of 2026, despite a more than 10% decline in the overall US mattress unit market. This profitability was driven by stronger metal margins, a favorable sales …

Quantinno Capital Management LP Grows Position in LegalZoom.com, Inc. $LZ

Quantinno Capital Management LP significantly increased its stake in LegalZoom.com, Inc. (NASDAQ:LZ) by 232.1% in the first quarter, now owning 393,823 shares valued at approximately $2.23 million. Despite LegalZoom exceeding EPS expectations and a 6.6% year-over-year revenue increase, the stock is trading near its …

Leggett & Platt (LEG) EVP Lindsey Odaffer granted additional common stock

Lindsey Nicole Odaffer, EVP - Chief HR Officer at Leggett & Platt (LEG), was granted 89.7554 shares of common stock on August 7, 2026, valued at $8.1770 per share. Following this transaction, her direct holdings increased to 86,825.5583 shares, and she also holds 25.2350 …

Earnings Flash (LEGN) Legend Biotech Corporation Posts Q2 Adjusted Net Income $0.16 per Share

Legend Biotech Corporation reported an adjusted net income of $0.16 per share for the second quarter of 2026. This financial announcement was made on August 11, 2026, and also included a reported Q2 revenue of $387.5 million, surpassing FactSet's estimate of $356.0 million. The …

LegalZoom.com Inc (LZ) Earnings Forecast: Future EPS & Revenue Growth Estimates

Why Legal & General (LSE:LGEN) Is Back in the Spotlight

£3,000 invested in Legal & General shares 1 year ago is now worth…

Legal & General Group PLC (LGGNF) (H1 2026) Earnings Call Highlights: Strong EPS Growth and ...

This article first appeared on GuruFocus. Core Operating Profit: Up 7% year-on-year, with 5% growth in institutional retirement, 10% in asset management, and 5% in retail. Core Operating EPS: Up 11% year-on-year, above the top end of the 6% to 9% guidance range. Operating …

Legacy Minerals Launches Drilling on Untested Gold‑Silver Targets at Mt Carrington

LegalZoom.com Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into LegalZoom.com (LZ)

Levi & Korsinsky, LLP is investigating potential securities law violations by LegalZoom.com (LZ) after the company's stock declined due to a reduced forward outlook. LegalZoom guided third-quarter revenue below analyst expectations and lowered full-year 2026 revenue guidance, leading to downgrades from JPMorgan and William …

Allegion PLC stock underperforms Monday when compared to competitors

Allegion PLC (ALLE) shares fell 2.02% to $165.53 on Monday, ending a six-day winning streak. This underperformance occurred on a generally negative trading day, with the S&P 500 Index declining 0.06% and the Dow Jones Industrial Average dropping 0.11%. The stock's dip was notable …

Allegiant Travel CO 2026: Revenue $943.49M, EPS ($0.21) — 10-Q Summary

Allegiant Travel CO reported Q2 2026 results with revenue increasing to $943.49M, a 36.9% year-over-year rise, and a significant reduction in net loss to ($4.86M), resulting in diluted EPS of ($0.21). Key drivers included higher fares, expanded network capacity, and the completed acquisition of …

ALLEGRO MICROSYSTEMS, INC. SEC Filing (Aug 10, 2026)

This article reports on an SEC Form 144 filing by ALLEGRO MICROSYSTEMS, INC. (ALGM) on August 10, 2026. The filing indicates a proposed sale of 2285 shares of common stock, acquired through restricted stock vesting on May 16, 2026, with an aggregate market value …

Allegiant Travel Drops 5.2% Amid Sector-Wide Selling

Allegiant Travel Company's shares dropped 5.2% to $90.64, mirroring a broad sell-off across the airline sector on Monday. This decline was not company-specific but part of a wider industry downturn, with major airlines experiencing significant losses. Investors are now questioning if this sector weakness …

Leggett & Platt (LEG) EVP Jennifer Davis reports stock grant award

Leggett & Platt (LEG) EVP and General Counsel, Jennifer Joy Davis, reported the acquisition of 113.2738 shares of common stock through a grant/award on August 7, 2026. The shares were valued at $8.1770 each, increasing her direct holdings to 119,476.9931 shares. This transaction was …

Leggett & Platt (LEG) EVP Robert S. Smith Jr. receives new stock grants

Robert S. Smith Jr., EVP and President of Specialized and FF&T at Leggett & Platt (LEG), received two equity awards of common stock on August 7, 2026. These grants totaled 341.4002 shares, with one award for 121.5054 shares at $8.1770 per share and another …